Skip to menu Skip to content Skip to footer

To identify and assess markers of prognosis, response and resistance to therapy in patients with Stage III metastatic melanoma (2013-2015)

Experts

Professor Mark Smithers

Emeritus Professor
Medical School
Faculty of Health, Medicine and Behavioural Sciences
Mark Smithers
Mark Smithers